Last reviewed · How we verify
NCT06848127: TR-EMA
Study of Emotional Dysregulation in Complex Post-Traumatic Stress Disorder
NA trial testing Self-questionnaires in Complex Post-Traumatic Stress Disorder (CPTSD) in 170 participants. Not yet recruiting.
1 March 2027
Quick facts
| Lead sponsor | University Hospital, Strasbourg, France |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 170 |
| Start date | 1 March 2025 |
| Primary completion | 1 March 2027 |
| Estimated completion | 1 December 2027 |
Drugs / interventions tested
- Self-questionnaires
- Cognitive assessment
- Momentary Ecological Assessment (EMA)
- Semi-structured interviews ITI and DSCID-II
Conditions studied
- Complex Post-Traumatic Stress Disorder (CPTSD) — all drugs for Complex Post-Traumatic Stress Disorder (CPTSD) →
- Borderline Personality Disorder (BPD) — all drugs for Borderline Personality Disorder (BPD) →
- Post-traumatic Stress Disorder (PTSD) — all drugs for Post-traumatic Stress Disorder (PTSD) →
Sponsor
University Hospital, Strasbourg, France
Who can join
18 and older, any sex, with Complex Post-Traumatic Stress Disorder (CPTSD) or Borderline Personality Disorder (BPD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD). As emotional dysregulation is a dynamic process whose phenomenological manifestations are labile, associated with physiological modifications and modulated by cognitive processing, a multiple methodology associating measurements in a real-life ecological context with measurements performed in the hospital will be preferred. Overall, this study proposes to capture, for the first time, the clinical manifestations associated with cPTSD from the perspective of emotional dysregulation and its underlying processes
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06848127
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Self-questionnaires
Trials testing the same drug.
- NCT05561283 — Evaluation of the Satisfaction and Relevance of Leadership Training for Residents · NA · completed
Other recruiting trials for Complex Post-Traumatic Stress Disorder (CPTSD)
Currently open trials in the same condition.
- NCT06975852 — Follow-Up Study on Children Exposed to Trauma · recruiting
Other University Hospital, Strasbourg, France trials
Trials by the same sponsor.
- NCT07418554 — Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Pla · Phase 3 · not yet recruiting
- NCT07108582 — Reducing Chronic Pain After Lung Surgery: A Trial of Limiting NSAIDs During Recovery · Phase 3 · not yet recruiting
- NCT07302646 — Optimizing Reduced-Flow, Low-Volume Contrast Protocols for Cerebral Angiography in Unruptured Aneurysms · NA · not yet recruiting
- NCT07273968 — Clinical Study Evaluating the Effect of Virtual Reality on Reducing Patients' Anxiety During Wisdom Teeth Extraction · NA · not yet recruiting
- NCT07214103 — Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulop · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06848127 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Strasbourg, France
- Last refreshed: 26 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06848127.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing